Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept.

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

Implementing NICE guidance
Well, shortly after a breakdown – I am talking about my own experience – you feel raw. You are very sensitive and you are easily hurt. It is not easy.
Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.
Co-ordinating action on drug issues Removing Stigma from our lives…… Raymond Garrity (Highland)
Healthcare Interpretation Network Trained Interpreters – an Important Member of the Care Team: The careprovider’s perspective Grace Eagan, MA UHN Interpretation.
Robin Pollard Operations Coordinator Youth RISE.
Out of Sight, Out of Time: Injection Drug Users, Hepatitis C, and HIV Policy Daniel Raymond Hepatitis C Policy Analyst Harm Reduction Coalition
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.
Advocacy 1. What is Advocacy? ● Organized effort to influence policy change/decision making ● Action directed at changing approach of an individual/institution/group.
Ethical Issues in Global Health Research Royal Institute of Health Sciences Thimphu, Bhutan Aug 13, 2013 Kaveh Khoshnood, PhD Associate Professor Yale.
ENGAGING WITH LAW ENFORCEMENT: PREVENTION, MONITORING AND RESPONSE Basha Silverman, Brandywine Counseling & Community Services.
GIPA/MIPA SOUTH AFRICA WORKPLACE MODEL. OUTLINE Background The GIPA principle: definition Why the GIPA principle? General lessons learned How far have.
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
©2003 Community Faculty Development Center Teaching Culture and Community in Primary Care: Teaching Culturally Appropriate Communication Skills.
Our Story Who am I? What makes me qualified to talk about anti- bullying? My personal story.
“Coming to fetch AIDS’’: Research participants talk about misconceptions and stories about HIV/AIDS and HIV vaccine research among community members Anthea.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
HIV, Drug Policy and Harm Reduction. Outreach in Moscow, Russia,1998.
Session 3 O PINION L EADER T RAINING. Session 3 2 Welcome to Session 3 Practicing Risk Reduction Conversations.
Harm Reduction.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
Lisa R. Norman, PhD Ponce School of Medicine and Health Sciences, Ponce, PR Harm Reduction International July 26, 2012.
Youth Satellite Meeting Sunday, May 13 th The International Youth Network for Harm Reduction.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
INTRODUCTION TO OUTREACH. A systematic approach of delivering HIV prevention services to people injecting drugs in their environments. WHAT DOES OUTREACH.
Young Offender Perspectives: What’s on their minds about a Successful Re-Entry.
Vocabulary Link Lesson B On a global scaleLesson A In my community Community issues Check (√) the items you have in your community. Then talk about.
Lifting the Federal Ban on the funding of syringe exchange: An advocacy campaign Allan Clear XVIII International AIDS Conference.
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
Opportunities for positive approaches to reducing underage drinking Dr Lisa Buckley.
SOCI3055A STUDIES IN ADDICTIONS February 13, 2007 INTERVENTIONS Drug Policy & Harm Reduction.
Olena Sakovych UNICEF Ukraine 1-2 November 2011 HIV/AIDS and drug use in the streets From evidence to action: experience from Ukraine.
 The underrepresentation of diverse populations in research an important barrier to: ◦ Understanding differences between groups ◦ Developing culturally.
What do donor’s think? Opportunities and challenges for stigma reduction programs and research R. Cameron Wolf, PhD Senior HIV/AIDS Advisor for Key Populations.
Chapter 16 Drugs Lesson 3 Staying Drug Free. Building Vocabulary drug free A characteristic of a person not taking illegal drugs or of a place where no.
SAFE PLACES GAME. With safe injection sites would there be an increased use of addiction treatment? The SIF's opening was associated independently with.
Tailored Harm Reduction Approaches: Bringing health care and social support to women drug users in Georgia Janna Ataiants, Nino Janashia, Ketevan Bidzinashvili,
Keeping up with the epidemic Programme success leaves us with new challenges: An evaluation of programmes for injecting sex workers.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Partnership Working Page 1 Celebrating Research and Partnership Working Conference Thursday 15 th October 2015 Dr Mashuq Ally – Assistant Director Equalities,
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
Prevention activities Session 14 Global Youth Network Workshop Needs Assessment & Programme Planning.
MAKING WELLNESS A LIFESTYLE Chapter 1. Wellness & Quality of Life Wellness is the state of being in good health Often associated with quality of life.
GETTING OUR ACT TOGETHER Jenny Williams Statutory Director – Social Care & Education Services Conwy County Borough Council.
GETTING OUR ACT TOGETHER. What are the building blocks for the Act? Moving us from  Fitting people to services  Eligibility as a means of saying ‘no’
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
1 Barriers to access to sterile syringes in Canada: legal, policy and human rights issues XVI International AIDS conference Tuesday, 15 August 2006 Alana.
Chapter 16 Drugs Lesson 3 Staying Drug Free.
Needle and syringe exchange and working with injecting drug users
The Efficacy of RN Supervised Safe Injection Sites
What is Community Housing Network?
Olena Sakovych UNICEF Ukraine 1-2 November 2011
The HIV Epidemic among People who Inject Drugs
STIs among people who use drugs
Biomedical Prevention Is Always About Social Justice, Too
Why do we fail in responding to the epidemic among people who use drugs? Insights from Vancouver M-J Milloy, PhD.
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
Suzanne Carlberg-Racich, MSPH, PHD
No conflicts of interest
Human Dignity and Harm Reduction
Presentation transcript:

Involving People living with HIV/AIDS: What does the Science Tell Us? Mark Tyndall & Thomas Kerr British Columbia Centre for Excellence in HIV/AIDS Dept. of Medicine, University of British Columbia

Involving Communities… The ethical imperative to involve people living with HIV/AIDS in policy development and program delivery is clear There is also scientific evidence supporting the principles outlined in GIPA

The Situation…  The policy response to HIV/AIDS among people who inject drugs (IDU) is inadequate and often harmful  The most commonly applied approach to injection drug use is to impose criminal sanctions  IDU are often driven into environments where they are difficult to locate for the purpose of providing prevention and risk reduction information and services  As a result, the most explosive HIV epidemics in the world have occurred among IDU

Challenges…  Service providers often experience difficulties in reaching and communicating with drug users and other marginalized groups on their own turf  IDU are also known to avoid seeking services out of fear that accessing them may alert police to their illegal activities  In response, IDU have become increasingly involved in policy change and development, and program delivery  A growing body of research demonstrates the far reaching effects of this form of involvement

The Benefits….  Increased acceptance  Improved reach & coverage  Able to focus on the most important issues  Cost-effectiveness  Provision of opportunities for training and employment  Reduction of stigma  Enhanced opportunities to translate policy into action (Broadhead et al., 1995; Broadhead et al., 1998; Grund et al., 1993; Power et al., 1995; Latkin, 1998; Cottler et al., 1998, Wood et al., 2003; Kerr et al., 2006)

Improved Reach and Coverage

Wood et al. Journal of Urban Health (3);

Improved Reach and Coverage “There was a tent set up. And there was a needle exchange going on there…And I thought ‘wow’, that's a lot better than running the van around and around… it's just convenient. It's on the street, it's there. Right where people score dope, like it’s not far to walk. And then I found out it was called VANDU…It just feels more safe. It's nice to have that convenience especially if you're IV drug using, cause needles are a big issue. Especially when people are doing cocaine or stuff like that. It's so easy to use another rig that's been used if you can't get a syringe, and if you can't afford to buy one…Actually I used to use the [fixed] needle exchange at DEYAS all the time. Now it's just more convenient for me to use VANDU. They're just, they're there more. They're where you need them…I find them where I need them.” (Program Recipient) Kerr et al., IJDP 2006

Improved Reach and Coverage

Reduced Stigma “It brings together a collective experience and wisdom, but also you begin to get a different feeling about yourself. To become part of something for who I am and not for who I am not. For who I am as an addict, I’m poor, I’ve got hep C, I lived in wretched housing and all this, and then someone says, ‘Yeah, that all makes you a really valuable person. You have a lot to contribute to try to help people and to save other lives, and your experience can do that.’ Then I get a different feeling about myself.”(Founder) Kerr et al., IJDP 2006

Kerr et al., Lancet 2004  IDU have played a major role in improving policies  The Thai Drug Users Network prompted the Global Fund to provide $1.4 USD for harm reduction programs despite significant government opposition

Resisting Oppression

Summary  A growing body of research has demonstrated the benefits of involving IDU in policy and program development and delivery  The involvement of IDU can improve the acceptance, reach, and coverage of programs  Involvement can also serve to reduce stigma and provide opportunities for training and low-threshold employment  IDU can also play an effective role in countering oppressive policies

Moving Forward  The GIPA principles are supported by research evidence – although more is needed  Governments and service providers should make efforts to promote the involvement of people living with HIV/AIDS in policy and program development and delivery  Involvement should be maximized by supporting the involvement of PLWA in formal systems and by supporting the development of independent PLWA groups  For many people, this is literally a life and death issue